New approach to immunotherapy leads to complete response in breast cancer patient

(NIH/National Cancer Institute) A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI's Center for Cancer Research (CCR), and the findings were published June 4, 2018 in Nature Medicine.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news